Immunoadsorption

Immunoadsorption is the technique by which pathogenic substances, especially undesirable antibodies, are removed from blood plasma. Immunoadsorption is considered to have fewer adverse effects than the use of therapeutic plasma exchange. Several medical conditions, such as multiple sclerosis and chronic inflammatory demyelinating polyneuropathy (CIDP) may use immunoadsorption as part of their medical regimen.

Theory
A number of studies have found that a subset of ME/CFS patients have abnormal autoantibodies in their blood; immunoadsorption could be used to remove these autoantibodies with the aim of improving symptoms or potentially curing ME/CFS in those patients.

Evidence

 * 2018, Immunoadsorption to remove ß2 adrenergic receptor antibodies in Chronic Fatigue Syndrome CFS/ME (Full Text)

Learn more

 * Wikipedia page for Immunoadsorption
 * 2018, Hope for an ME/CFS Autoimmune Subset: A German Researcher Steps Forward (Carmen Scheibenbogen)